Latest filing published 03 Aug 2017 for Oramed Pharmaceuticals INC., €643k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -37.8%Entry US$8.04 · Close at T+365 US$5.00
- +14.6%Entry US$6.44 · Close at T+365 US$7.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Xiaopeng Li: trading record in brief
Xiaopeng Li discloses dealings in Oramed Pharmaceuticals Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 7 November 2016 to 2 August 2017.
On the market, this insider has only ever bought: 2 purchases, €955k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant. So far in 2017, the count stands at 2 purchases and no sales.
Most recently, on 3 August 2017, the filings show an open-market purchase worth €643k in Oramed Pharmaceuticals Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Xiaopeng Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 89,636 shares@ US$8.5046.5% of flowCOMMON STOCKSEC:0001213900-17-008214:0Canonical exit: 31 Oct 2017 (T+90)
- 52,814 shares@ US$6.3322.6% of flowCommon StockSEC:0001178913-17-001172:0Canonical exit: 18 Jul 2017 (T+90)
- 63,900 shares@ US$7.4230.9% of flowCommon StockSEC:0001213900-16-018027:0
3 of 3 declarations
